LUNG vs CTKB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

LUNG

32.6
AI Score
VS
CTKB Wins

CTKB

49.2
AI Score

Investment Advisor Scores

LUNG

33score
Recommendation
SELL

CTKB

49score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric LUNG CTKB Winner
Revenue 66.18M 145.50M CTKB
Net Income -32.13M -37.12M LUNG
Gross Margin 77.3% 55.5% LUNG
Net Margin -48.5% -25.5% CTKB
Operating Income -29.50M -38.29M LUNG
ROE -93.9% -11.6% CTKB
ROA -29.2% -8.3% CTKB
Total Assets 110.21M 446.14M CTKB
Cash 52.69M 66.81M CTKB
Current Ratio 4.05 4.46 CTKB
Free Cash Flow -18.51M -11.71M CTKB

Relative Price Performance (Last 90 Days)

LUNG 1M: +55.6% · 3M: +22.3% CTKB 1M: +9.0% · 3M: +21.1%

Current Technical Phase

LUNG

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.6% over 20 days), RSI 62

RSI (14): 62.5 · Price: $2.80

CTKB

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (8.9% over 20 days), RSI 53

RSI (14): 52.7 · Price: $5.79

Fundamentals Snapshot

Metric LUNG CTKB
Market Cap — —
Forward P/E -3.1 -20.3
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.8% 0.5%
Operating Margin -0.3% -0.2%
EPS -1.01 -0.63
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CTKB is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.